Human Rabies Vaccine (Vero Cell)人用狂犬病疫苗(Vero细胞)

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

灭活是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:灭活Mie Huo、经浓缩Jingnong Suo。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:灭活-33f96604成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 人用狂犬病疫苗(Vero细胞)) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 灭活Mie Huo, 经浓缩Jingnong Suo.

Explore other medicines containing the same ingredient: 灭活 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 人用狂犬病疫苗(Vero细胞)Human Rabies Vaccine (Vero Cell)
  • 规格Specification: 每瓶1.0mlRecorded Chinese specification: 每瓶1.0ml

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 吉林迈丰生物药业有限公司Chinese legal name: 吉林迈丰生物药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字S20060076

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字S20060076

Manufacturer

Chinese legal name: 吉林迈丰生物药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字S20060076

生产企业

吉林迈丰生物药业有限公司(国产)

适应症

凡被患有或可疑患有狂犬病的动物咬伤、抓伤后,不分年龄、性别均应及时按暴露后免疫程序注射本疫苗;凡有接触狂犬病病毒危险人员(如兽医、动物饲养员、林业从业人员、猎人、屠宰场工人、狂犬病实验人员、动物标本制作者、洞穴居住者、动物聚居区的儿童、成人和经常观光的旅游者等),按照暴露前免疫程序接种进行免疫接种。

用法用量

1? 凡被狂犬或其它疯动物

不良反应

本疫苗可能对个别接种者产生不同程度的不良反应。局部反应:接种部位疼痛、红斑、水肿、瘙痒、硬结。全身反应:轻微发热、寒战、晕厥、乏力、头痛、眩晕、关节痛、肌肉痛、胃肠道功能混乱。另外,也有可能出现极个别的过敏反应、神经性水肿、皮疹、荨麻疹。若出现本说明书中未注明的任何不良反应时,应及时向医生报告。

禁忌

由于狂犬病是致死性疾病,暴露后程序接种疫苗无任何禁忌症。||暴露前程序接种时遇发热、急性疾病、慢性病的活动期、神经系统疾病、过敏性疾病或对已知任何疫苗成份有过敏史者禁用。哺乳期、妊娠期妇女建议推迟注射本疫苗。

注意事项

(1)本疫苗不能进行血管内注射,禁止针头插入血管。(2)抗狂犬病血清(或抗狂犬病免疫球蛋白)和本疫苗绝不能使用同一支注射器,也绝不能在同一部位注射。(3)禁止臀部注射。(4)疫苗接种时,忌饮酒、浓茶等刺激性食物及剧烈运动等。(5)疫苗有异物、瓶有裂纹或标签不清者,均不得使用。(6)本疫苗禁止冻结。

贮藏

于2~8℃避光保存和运输。

规格

每瓶1.0ml

证据Evidence

  • 批准文号: 国药准字S20060076
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.